Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections: prolonged or continuous infusion?
about
Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patients.Identification of optimal renal dosage adjustments for traditional and extended-infusion piperacillin-tazobactam dosing regimens in hospitalized patients.Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.Nonlinear pharmacokinetics of piperacillin in healthy volunteers--implications for optimal dosage regimensBacterial membrane disrupting dodecapeptide SC4 improves survival of mice challenged with Pseudomonas aeruginosa.Piperacillin-tazobactam penetration into human pancreatic juice.Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.Continuing education: alternative approaches to optimizing antimicrobial pharmacodynamics in critically ill patients.β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.Molecular Adsorbent Recirculating System (MARS(®)) removal of piperacillin/tazobactam in a patient with acetaminophen-induced acute liver failure.Prolonged infusions of β-lactam antibiotics: implication for antimicrobial stewardship.Using higher doses to compensate for tubing residuals in extended-infusion piperacillin-tazobactam.Antimicrobial Stewardship in the Emergency Department: Challenges, Opportunities, and a Call to Action for Pharmacists.Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance.The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections.Clinical Outcomes of Extended Versus Intermittent Infusion of Piperacillin/Tazobactam in Critically Ill Patients: A Prospective Clinical Trial.Pharmacokinetics of an extended 4-hour infusion of piperacillin-tazobactam in critically ill patients undergoing continuous renal replacement therapy.Experience with extended infusion of piperacillin-tazobactam at a teaching hospital.Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumonia.Simplifying Piperacillin/Tazobactam Dosing: Pharmacodynamics of Utilizing Only 4.5 or 3.375 g Doses for Patients With Normal and Impaired Renal Function.Development and implementation of a piperacillin-tazobactam extended infusion guideline.
P2860
Q33508985-CA1D8F8C-0D8F-4380-99B8-8C924DBF9A22Q33559047-61DC24E6-B28C-45EE-9821-71364E3CCEF8Q34058137-835B9D12-0EBD-4C8E-8B2A-8DAFD516379FQ34381321-0A19CEE1-D064-4F97-AB4F-453CA4B91C25Q35984984-AF75C9BF-66B3-42E4-8771-06BD10076E43Q36949427-E1F114E7-051A-45E1-BF22-9BD8C1EAE7FDQ37516599-55309FE1-28CD-479E-AF10-554F86EBF349Q37656243-5AA41E58-0C45-4BE7-B9A9-C52DBB2B7B5EQ37867260-ED692A5E-5C61-420D-83DA-BCA3A82AF9B0Q38004063-83846E5F-BA3D-4DC3-A741-AF0C8E61797FQ38070907-67FE4A6D-901A-4BA7-BD35-6AF1F5D63265Q38073197-25623702-FFEE-4FF3-8A36-CDC3F290B086Q38110142-6435CFEF-E8EA-46B7-9819-BDC881F4A3C2Q38512185-3D589A64-795C-4274-8551-7D5EE782890BQ38672016-3AB8A58D-E7FE-414C-9E7D-D54C6925C6D7Q38864569-FD8331D1-7E43-4187-A078-DE61CD6DA47AQ40078698-5399C88D-43C6-4120-BF3E-08C3064901FAQ41148311-EE47D2D5-C2F1-4D05-B81D-C7E95EDCA6C7Q42735006-06F29A9A-2CBF-4658-A273-A1AC65586D8FQ43153489-EA84225D-453F-413A-98BA-29376C9B6CD4Q50089280-94A2E2E3-4A1D-4C73-8481-5DA6A10CB794Q51165719-A7246685-DF7D-418C-AC69-4909240990A6
P2860
Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections: prolonged or continuous infusion?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Optimal dosing of piperacillin ...... longed or continuous infusion?
@en
Optimal dosing of piperacillin ...... longed or continuous infusion?
@nl
type
label
Optimal dosing of piperacillin ...... longed or continuous infusion?
@en
Optimal dosing of piperacillin ...... longed or continuous infusion?
@nl
prefLabel
Optimal dosing of piperacillin ...... longed or continuous infusion?
@en
Optimal dosing of piperacillin ...... longed or continuous infusion?
@nl
P2093
P2860
P356
P1433
P1476
Optimal dosing of piperacillin ...... longed or continuous infusion?
@en
P2093
Christina A Sutherland
David P Nicolau
Joseph L Kuti
P2860
P304
P356
10.1592/PHCO.27.11.1490
P407
P577
2007-11-01T00:00:00Z